questionsmedicales.fr
Composés chimiques organiques
Composés onium
Composés d'ammonium quaternaire
Néostigmine
Néostigmine : Questions médicales fréquentes
Diagnostic
5
Myasthénie
Diagnostic médical
Néostigmine
Évaluation clinique
Faiblesse musculaire
Néostigmine
Effets secondaires
Néostigmine
Examen neurologique
Néostigmine
Symptômes
5
Crise myasthénique
Symptômes
Urgence médicale
Néostigmine
Prévention
5
Crises myasthéniques
Prévention
Conseils aux patients
Néostigmine
Suivi médical
Néostigmine
Traitements
5
Néostigmine
Administration de médicaments
Immunosuppresseurs
Néostigmine
Interactions médicamenteuses
Néostigmine
Complications
5
Complications
Néostigmine
Gestion de crise
Néostigmine
Problèmes cardiaques
Néostigmine
Signes d'alerte
Néostigmine
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Néostigmine : Questions médicales les plus fréquentes",
"headline": "Néostigmine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Néostigmine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-22",
"dateModified": "2026-07-12",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Néostigmine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Composés d'ammonium quaternaire",
"url": "https://questionsmedicales.fr/mesh/D000644",
"about": {
"@type": "MedicalCondition",
"name": "Composés d'ammonium quaternaire",
"code": {
"@type": "MedicalCode",
"code": "D000644",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.675.276"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Néostigmine",
"alternateName": "Neostigmine",
"code": {
"@type": "MedicalCode",
"code": "D009388",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Tak Kyu Oh",
"url": "https://questionsmedicales.fr/author/Tak%20Kyu%20Oh",
"affiliation": {
"@type": "Organization",
"name": "Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Gumi-ro 173 Beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea."
}
},
{
"@type": "Person",
"name": "Stephania Paredes",
"url": "https://questionsmedicales.fr/author/Stephania%20Paredes",
"affiliation": {
"@type": "Organization",
"name": "From the Department of Outcomes Research."
}
},
{
"@type": "Person",
"name": "Julie John",
"url": "https://questionsmedicales.fr/author/Julie%20John",
"affiliation": {
"@type": "Organization",
"name": "Hendrick Medical Center."
}
},
{
"@type": "Person",
"name": "Greg Perry",
"url": "https://questionsmedicales.fr/author/Greg%20Perry",
"affiliation": {
"@type": "Organization",
"name": "Hendrick Medical Center."
}
},
{
"@type": "Person",
"name": "Jeremie Perry",
"url": "https://questionsmedicales.fr/author/Jeremie%20Perry",
"affiliation": {
"@type": "Organization",
"name": "Hendrick Medical Center."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Comparison of Effects of Sugammadex and Neostigmine on Postoperative Neuromuscular Blockade Recovery in Patients with Interstitial Lung Diseases Undergoing Transbronchial Cryobiopsy: A Randomized Trial.",
"datePublished": "2024-05-01",
"url": "https://questionsmedicales.fr/article/38689479",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.12659/MSM.942773"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sugammadex and urinary retention after hysterectomy: A propensity-matched cohort study.",
"datePublished": "2024-03-11",
"url": "https://questionsmedicales.fr/article/37715536",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.17305/bb.2023.9569"
}
},
{
"@type": "ScholarlyArticle",
"name": "Post-operative urinary retention is impacted by neuromuscular block reversal agent choice: A retrospective cohort study in US hospital setting.",
"datePublished": "2023-11-25",
"url": "https://questionsmedicales.fr/article/38007845",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jclinane.2023.111344"
}
},
{
"@type": "ScholarlyArticle",
"name": "Risk analysis of postoperative nausea and vomiting in patients after gynecologic laparoscopic surgery.",
"datePublished": "2024-09-28",
"url": "https://questionsmedicales.fr/article/39342087",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12871-024-02727-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Shortened time to neuromuscular recovery with lower doses of rocuronium in elderly patients.",
"datePublished": "2024-05-13",
"url": "https://questionsmedicales.fr/article/38847412",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.61409/A09230578"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés onium",
"item": "https://questionsmedicales.fr/mesh/D009861"
},
{
"@type": "ListItem",
"position": 4,
"name": "Composés d'ammonium quaternaire",
"item": "https://questionsmedicales.fr/mesh/D000644"
},
{
"@type": "ListItem",
"position": 5,
"name": "Néostigmine",
"item": "https://questionsmedicales.fr/mesh/D009388"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Néostigmine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Néostigmine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-08-25",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Néostigmine",
"description": "Comment diagnostiquer une myasthénie grave ?\nQuels tests sont utilisés pour évaluer l'efficacité de la néostigmine ?\nQuels symptômes indiquent un besoin de néostigmine ?\nComment évaluer les effets secondaires de la néostigmine ?\nQuels examens sont nécessaires avant un traitement par néostigmine ?",
"url": "https://questionsmedicales.fr/mesh/D009388#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Néostigmine",
"description": "Quels sont les symptômes de la myasthénie grave ?\nLa néostigmine peut-elle provoquer des nausées ?\nQuels signes indiquent une surdose de néostigmine ?\nComment reconnaître une crise myasthénique ?\nQuels symptômes nécessitent une attention médicale urgente ?",
"url": "https://questionsmedicales.fr/mesh/D009388#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Néostigmine",
"description": "Comment prévenir les effets secondaires de la néostigmine ?\nY a-t-il des précautions à prendre avant de commencer la néostigmine ?\nComment éviter les crises myasthéniques ?\nQuels conseils pour les patients sous néostigmine ?\nLa néostigmine nécessite-t-elle un suivi régulier ?",
"url": "https://questionsmedicales.fr/mesh/D009388#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Néostigmine",
"description": "Comment la néostigmine est-elle administrée ?\nQuels sont les traitements alternatifs à la néostigmine ?\nLa néostigmine est-elle utilisée en anesthésie ?\nQuels médicaments interagissent avec la néostigmine ?\nQuelle est la posologie standard de néostigmine ?",
"url": "https://questionsmedicales.fr/mesh/D009388#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Néostigmine",
"description": "Quelles sont les complications possibles de la néostigmine ?\nComment gérer une crise myasthénique ?\nQuels sont les risques d'une surdose de néostigmine ?\nLa néostigmine peut-elle causer des problèmes cardiaques ?\nQuels signes d'alerte doivent être surveillés ?",
"url": "https://questionsmedicales.fr/mesh/D009388#section-complications"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une myasthénie grave ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests de force musculaire et des analyses sanguines."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'efficacité de la néostigmine ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de force musculaire et des évaluations cliniques sont réalisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un besoin de néostigmine ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une faiblesse musculaire fluctuante et une fatigue accrue sont des indicateurs."
}
},
{
"@type": "Question",
"name": "Comment évaluer les effets secondaires de la néostigmine ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation se fait par l'observation des symptômes et des tests de laboratoire."
}
},
{
"@type": "Question",
"name": "Quels examens sont nécessaires avant un traitement par néostigmine ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un examen neurologique et des tests sanguins sont souvent requis."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de la myasthénie grave ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent faiblesse musculaire, ptosis et diplopie."
}
},
{
"@type": "Question",
"name": "La néostigmine peut-elle provoquer des nausées ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les nausées sont un effet secondaire possible de la néostigmine."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une surdose de néostigmine ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes incluent salivation excessive, spasmes musculaires et bradycardie."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une crise myasthénique ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une crise se manifeste par une faiblesse musculaire sévère et des difficultés respiratoires."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent une attention médicale urgente ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des difficultés respiratoires ou une faiblesse musculaire extrême nécessitent une urgence."
}
},
{
"@type": "Question",
"name": "Comment prévenir les effets secondaires de la néostigmine ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et un ajustement de la dose peuvent aider."
}
},
{
"@type": "Question",
"name": "Y a-t-il des précautions à prendre avant de commencer la néostigmine ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, informer le médecin des allergies et des médicaments en cours est crucial."
}
},
{
"@type": "Question",
"name": "Comment éviter les crises myasthéniques ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement régulier et un suivi médical peuvent réduire le risque de crises."
}
},
{
"@type": "Question",
"name": "Quels conseils pour les patients sous néostigmine ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Respecter la posologie et signaler tout effet indésirable au médecin."
}
},
{
"@type": "Question",
"name": "La néostigmine nécessite-t-elle un suivi régulier ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier est essentiel pour ajuster le traitement si nécessaire."
}
},
{
"@type": "Question",
"name": "Comment la néostigmine est-elle administrée ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "La néostigmine peut être administrée par voie orale ou injectable."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements alternatifs à la néostigmine ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des immunosuppresseurs et des thérapies plasmaphérèses peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "La néostigmine est-elle utilisée en anesthésie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est utilisée pour inverser les effets des agents neuromusculaires."
}
},
{
"@type": "Question",
"name": "Quels médicaments interagissent avec la néostigmine ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les anticholinergiques peuvent réduire son efficacité."
}
},
{
"@type": "Question",
"name": "Quelle est la posologie standard de néostigmine ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La posologie varie, mais elle est généralement de 15 à 375 mg par jour."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de la néostigmine ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles respiratoires et des crises myasthéniques."
}
},
{
"@type": "Question",
"name": "Comment gérer une crise myasthénique ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une intervention médicale rapide et l'administration de néostigmine sont nécessaires."
}
},
{
"@type": "Question",
"name": "Quels sont les risques d'une surdose de néostigmine ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surdose peut entraîner des symptômes graves comme des convulsions et la mort."
}
},
{
"@type": "Question",
"name": "La néostigmine peut-elle causer des problèmes cardiaques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut provoquer des bradycardies et d'autres troubles cardiaques."
}
},
{
"@type": "Question",
"name": "Quels signes d'alerte doivent être surveillés ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Surveiller les signes de surdosage, comme la salivation excessive et la faiblesse extrême."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 12/07/2026
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Gumi-ro 173 Beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea.
Interdepartment of Critical Care Medicine, Seoul National University Bundang Hospital, 166, Gumi-ro 173 Beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, 463-707, Republic of Korea.
Publications dans "Néostigmine" :
3 publications dans cette catégorie
Affiliations :
From the Department of Outcomes Research.
Department of General Anesthesiology, Anesthesiology Institute, Cleveland Clinic, Cleveland, Ohio.
Publications dans "Néostigmine" :
2 publications dans cette catégorie
Publications dans "Néostigmine" :
2 publications dans cette catégorie
Publications dans "Néostigmine" :
2 publications dans cette catégorie
Publications dans "Néostigmine" :
2 publications dans cette catégorie
Affiliations :
Texas Tech University Health Sciences Center, School of Pharmacy.
Publications dans "Néostigmine" :
2 publications dans cette catégorie
Affiliations :
Texas Tech University Health Sciences Center, School of Pharmacy.
Publications dans "Néostigmine" :
2 publications dans cette catégorie
Affiliations :
Texas Tech University Health Sciences Center, School of Pharmacy.
Publications dans "Néostigmine" :
2 publications dans cette catégorie
Affiliations :
Texas Tech University Health Sciences Center, School of Pharmacy.
Publications dans "Néostigmine" :
2 publications dans cette catégorie
Affiliations :
Texas Tech University Health Sciences Center, School of Pharmacy.
Publications dans "Néostigmine" :
2 publications dans cette catégorie
Affiliations :
Department of Anesthesiology, The Second Xiangya Hospital, Central South University, Changsha, China.
Publications dans "Néostigmine" :
2 publications dans cette catégorie
Affiliations :
From the Department of Outcomes Research.
Publications dans "Néostigmine" :
2 publications dans cette catégorie
Affiliations :
From the Department of Outcomes Research.
Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio.
Publications dans "Néostigmine" :
2 publications dans cette catégorie
Affiliations :
From the Department of Outcomes Research.
Department of General Anesthesiology, Anesthesiology Institute, Cleveland Clinic, Cleveland, Ohio.
Publications dans "Néostigmine" :
2 publications dans cette catégorie
Affiliations :
From the Department of Outcomes Research.
Department of General Anesthesiology, Anesthesiology Institute, Cleveland Clinic, Cleveland, Ohio.
Publications dans "Néostigmine" :
2 publications dans cette catégorie
Affiliations :
From the Departments of Anesthesiology and Pain Medicine.
Publications dans "Néostigmine" :
2 publications dans cette catégorie
Affiliations :
Department of Biostatistics, University of Washington School of Public Health, Seattle, Washington.
Publications dans "Néostigmine" :
2 publications dans cette catégorie
Affiliations :
Department of Anesthesiology, Duke University, Durham, North Carolina.
Publications dans "Néostigmine" :
2 publications dans cette catégorie
Affiliations :
From the Departments of Anesthesiology and Pain Medicine.
Publications dans "Néostigmine" :
2 publications dans cette catégorie
Affiliations :
Department of Anesthesiology, University of Cincinnati, Cincinnati, OH, United States of America. Electronic address: william.hurford@uc.edu.
Publications dans "Néostigmine" :
BACKGROUND While many studies have been conducted on sugammadex sodium and neostigmine in patients undergoing general anesthesia, few have explored their effects in patients with interstitial lung dis...
Postoperative urinary retention (POUR) is a well-known complication after gynecologic surgery. Our objective was to investigate whether the choice of pharmacologic agent for reversing neuromuscular bl...
Perioperative neuromuscular blocking agents are pharmacologically reversed to minimize complications associated with residual neuromuscular block. Neuromuscular block reversal with anticholinesterases...
Retrospective cohort study utilizing large healthcare database....
Non-profit, non-governmental and community and teaching hospitals and health systems from rural and urban areas....
61,898 matched adult inpatients and 95,500 matched adult outpatients....
Neuromuscular block reversal with sugammadex or neostigmine plus glycopyrrolate....
Incidence of post-operative urinary retention by neuromuscular block reversal agent and the independent association of neuromuscular block reversal technique and risk of post-operative urinary retenti...
The incidence of post-operative urinary retention was 2-fold greater among neostigmine with glycopyrrolate compared to sugammadex patients (5.0% vs 2.4% inpatients; 0.9% vs 0.4% outpatients; both p < ...
Though this study suggests that neuromuscular block reversal with neostigmine can increase post-operative urinary retention risk, additional studies are needed to fully understand the association....
This study is designed to identify risk factors of postoperative nausea and vomiting (PONV) in patients after gynecologic laparoscopic surgery and establish a nomogram model....
In this retrospective and multicenter study, we collected and analyzed data from 1233 patients who underwent gynecologic laparoscopic surgery. The Lasso algorithm was used to optimize the selection of...
The dosage of sufentanil in patient-controlled intravenous analgesia (PCIA), the dosage of remifentanil, the use of neostigmine, duration of surgery and the maximum value of the P...
A nomogram model was developed to predict the incidence of PONV in patients after gynecologic laparoscopic surgery. This model was found to be reliable and of high clinical value....
The effect of neuromuscular blocking agents may be reversed by administration of neostigmine, when two twitches are present using train-of-four (TOF) stimulation. However, in elderly patients, limited...
This was a secondary analysis of 50 elderly patients > 80 years; 16 patients received rocuronium 0.6 mg/kg, another 16 patients received rocuronium 0.9 mg/kg; and, finally, 18 patients received rocuro...
Time to TOF-2 was shorter after rocuronium 0.6 mg/kg than after rocuronium 0.9 mg/kg: 37 min. versus 59 min. (difference: 22 min. (95% confidence intervals (CI): 10 to 33 min.), p = 0.0007). Time to T...
Time to TOF-2 was shorter after rocuronium 0.6 mg/kg than after 0.9 mg/kg and shorter after rocuronium 0.3 mg/kg than after 0.6 mg/kg....
This work was supported by departmental sources....
This study was a secondary analysis of two clinical trials....
gov (NCT04512313), (NCT03857750)....
Postoperative urinary retention (POUR) is a common surgical complication that can result in bladder overdistension, urinary tract infection and an extended hospital stay. Although neostigmine is an ef...
Carbamazepine is utilized for various indications. Due to its pharmacokinetic profile and drug properties, toxicity can be delayed and persistent despite supportive care. We report a severe case of in...
The use of neuromuscular blocking agents (NMBA) has grown due to the development of laparoscopic and minimally invasive procedures. Respiratory insufficiency, an elevated risk of aspiration, postopera...
Our previous work demonstrated that the anisodamine (ANI) and neostigmine (NEO) combination produced an antiseptic shock effect and rescued acute lethal crush syndrome by activating the α7 nicotinic a...
Administration of cholinesterase inhibitors in combination with anticholinergic drugs for reversal of neuromuscular blocks may precipitate delirium through impairment of central cholinergic transmissi...
We conducted a single-center retrospective cohort study, analyzing all adult patients having general anesthesia for noncardiac surgery who received neostigmine or sugammadex from January 2016 to March...
Among 49,468 cases in our analysis, 6881 received sugammadex and 42,587 received neostigmine. After propensity weighting, the incidence of delirium was 1.09% in the sugammadex group and 0.82% in the n...
Compared to neostigmine, use of sugammadex for reversal of neuromuscular block was not associated with an increased risk of postoperative delirium in this retrospective single-center study. Though sug...